Frazier Life Sciences Acquisition Corp. II — Form SCHEDULE 13D
Filed October 21, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 28/100
What the filing says
Frazier Life Sciences Holdings II LLC filed a Schedule 13D regarding beneficial ownership of Frazier Life Sciences Acquisition Corp. II (a blank-check company, SIC 6770). The filing was submitted on 2026-10-21. Specific ownership percentages, share counts, acquisition dates, and dollar amounts are not disclosed in the header metadata provided; the complete filing details are in linked documents (primary_doc.html/xml and exhibit EX-99.1.pdf) not reproduced here.
Why this rating
Schedule 13D by affiliate of blank-check SPAC; no price, shares, or % disclosed in accessible text. Routine regulatory disclosure for SPAC structure.
See more from October 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.